Mechanisms of action of antiestrogens: relevance to clinical benefits and risks.
Carmichael
P L
PL
Division of Biomedical Sciences, Molecular Toxicology, Imperial College, London, United Kingdom.
D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy*; D002273:Carcinogens; D019008:Drug Resistance, Neoplasm; D016889:Endometrial Neoplasms / Q000139:chemically induced / Q000175:diagnosis; D004965:Estrogen Antagonists / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced; D009153:Mutagens; D051381:Rats; D012306:Risk; D013629:Tamoxifen / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects
D002273:Carcinogens; D004965:Estrogen Antagonists; D009153:Mutagens; D013629:Tamoxifen